Sympathetic Nervous Activation in Essential Hypertension: Commonly Neglected as a Therapeutic Target, Usually Ignored as a Drug Side Effect

Hypertension - United States
doi 10.1161/hypertensionaha.110.151506
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

Suppression of Sympathetic Nervous Function in Low-Renin Essential Hypertension

The Lancet
Medicine
1976English

BMP Type II Receptor as a Therapeutic Target in Pulmonary Arterial Hypertension

Cellular and Molecular Life Sciences
Molecular NeuroscienceMolecular MedicineCell BiologyMolecular BiologyPharmacologyCellular
2017English

Interleukin-6 as a Potential Therapeutic Target for Pulmonary Arterial Hypertension

International Journal of Rheumatology
RheumatologyImmunology
2010English

Lysosomes as a Therapeutic Target

Nature Reviews Drug Discovery
MedicineDrug DiscoveryPharmacology
2019English

CD38 as a Therapeutic Target

Molecular Medicine
Molecular MedicineGeneticsMolecular Biology
2006English

Nrf2 Activation as Target to Implement Therapeutic Treatments

Frontiers in Chemistry
Chemistry
2015English

Tax as a Therapeutic Target in ATL

Retrovirology
VirologyInfectious Diseases
2015English

Inflammation as a Therapeutic Target in Atherosclerosis

Journal of Clinical Medicine
2019English

Candida Albicansdimorphism as a Therapeutic Target

Expert Review of Anti-Infective Therapy
VirologyInfectious DiseasesMicrobiology
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy